Speaker illustration

Associate Professor Henning Steen

Marien Hospital Hamburg, Hamburg (Germany)

Intramyocardial fast-SENC is less impacted by compensatory mechanisms while monitoring cardiotoxic effects of chemotherapy than echocardiography and conventional CMR: the PREFECT study

Event: ESC Congress 2020

Topic: Imaging

Session: What’s New in the Diagnostics of Acute Heart Failure: Imaging Tools and Biomarkers

Thumbnail

CMR Fast-SENC intramyocardial LV & RV segmental strain helps manage cardioprotective therapy in patients exhibiting cardiotoxicity during cancer treatment

Event: ESC Congress 2019

Topic: Cardiotoxicity of Drugs and Other Therapies

Session: Imaging in heart failure

Thumbnail

Classifying heart failure patients based on objective Fast-SENC cardiac MRI measurements instead of subjective NYHA symptomatic criteria

Event: Heart Failure 2019

Topic: Imaging

Session: Chronic Heart Failure – Diagnostic Methods

Thumbnail

Prevention of heart failure with cardioprotective therapy after early detection of cardiotoxicity during chemotherapy in cancer patients using CMR Fast-SENC intramyocardial LV & RV strain

Event: Heart Failure 2019

Topic: Cardiotoxicity of Drugs and Other Therapies

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb